72.11.Z - Research and experimental development on biotechnology
46.45.Z - Wholesale of perfume and cosmetics
46.46.Z - Wholesale of pharmaceutical goods
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.91.Z - Retail sale via mail order houses or via Internet
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, except copyrighted works
86.90.D - Paramedical activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,3 | -0,1 | -0,1 | 2,4 |
EBITDA | -0,2 | -0 | -0 | 87,6 |
Short time liabilities | 0,3 | 0,4 | 0,5 | 18,1 |
Equity capital | -1,6 | -1,6 | -1,7 | -4,3 |
Operating profit (EBIT) | -0,2 | -0 | -0 | 87,6 |
Assets | 0,1 | 0,1 | 0,1 | 0 |
Net profit (loss) | -0,3 | -0,1 | -0,1 | 2,4 |
Cash | 0 | 0 | 0 | 0 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 1,7 | 1,8 | 1,9 | 3,9 |
Working assets | 0,1 | 0,1 | 0,1 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 18,8 | 4,4 | 4,1 | -0,3 |
Equity capital to total assets | -1050,8 | -1107,6 | -1154,4 | -46,8 |
Gross profit margin | -1173,5 | 523 264,2 | ||
EBITDA Margin | -942,2 | 307 173,1 | ||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 4619 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.3672553300857544 | 0.2974981367588043 | 0.2521272897720337 | 0 |
Net dept to EBITDA | -5.913483619689941 | -724.4306640625 | -5855.55322265625 | -5131,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane